Synthesis Route for 1H-Imidazole-4,5-Dicarbonitrile: Industrial Process & Scalable Manufacturing
- Industrial-scale synthesis of 4,5-Imidazoledicarbonitrile leverages optimized one-pot routes with high regioselectivity and yield.
- Key intermediates like 1,4-dinitroimidazoles enable efficient cine-substitution using cyanide under mild aqueous-methanolic conditions.
- NINGBO INNO PHARMCHEM CO.,LTD. supplies bulk quantities of high-purity 1H-Imidazole-4,5-dicarbonitrile (CAS 1122-28-7) with full COA documentation for pharmaceutical R&D.
The compound 1H-Imidazole-4,5-dicarbonitrile (also known as 4,5-Imidazoledicarbonitrile, 4,5-Dicyanoimidazole, or DCI; CAS 1122-28-7) is a critical heterocyclic building block in medicinal chemistry, particularly valued for its role in constructing purine analogs and antiviral scaffolds. Its electron-deficient imidazole core, flanked by two nitrile groups, offers versatile reactivity for nucleophilic substitution, cycloaddition, and metal-catalyzed cross-coupling—making it indispensable in the synthesis of kinase inhibitors, flavivirus antagonists, and advanced condensation reagents.
Classic Tetramer-Based Synthesis from Hydrogen Cyanide
Historically, early routes to imidazole-based dinitriles relied on tetramerization of hydrogen cyanide (HCN), a process that, while conceptually elegant, suffers from poor regiocontrol and low functional group tolerance. This method typically yields complex mixtures of imidazole, pyrazine, and triazine derivatives, requiring extensive purification and resulting in suboptimal yields of the desired Imidazole-4,5-dicarbonitrile. Consequently, this approach is rarely employed in modern industrial settings due to safety concerns (handling gaseous HCN) and scalability limitations.
Modern One-Pot Methods for 4,5-Dicyanoimidazole Production
Contemporary industrial synthesis has shifted toward highly regioselective strategies based on functionalized imidazole precursors. A well-established and scalable route involves the cine-substitution of 1,4-dinitroimidazole with cyanide ion—a transformation first reported in specialized literature and now refined for large-batch production.
In this method, 1,4-dinitro-1H-imidazole undergoes nucleophilic aromatic substitution where the nitro group at the 4-position is displaced by cyanide under mild conditions. The reaction proceeds efficiently in aqueous methanol with sodium bicarbonate as a buffering agent, yielding 1H-Imidazole-4,5-dicarbonitrile in >85% isolated yield after crystallization. The use of NaCN or KCN in controlled stoichiometry ensures minimal formation of mono-cyano byproducts, while the aqueous-organic solvent system facilitates easy workup and waste stream management.
This route is particularly advantageous because:
- It starts from commercially available or easily synthesized dinitroimidazole;
- Operates at ambient to moderate temperatures (25–50°C);
- Exhibits excellent atom economy and minimal heavy metal usage;
- Produces water-soluble inorganic salts as the primary co-product.
Scalability and Yield Optimization in Industrial Manufacturing
At the industrial scale, the key to economic viability lies in consistent yield, purity, and batch-to-batch reproducibility. NINGBO INNO PHARMCHEM CO.,LTD.—a premier global manufacturer of specialty heterocycles—has optimized the cine-substitution protocol for multi-hundred-kilogram production runs of 4,5-Dicyanoimidazole. Their process achieves:
| Parameter | Performance Metric |
|---|---|
| Reaction Yield | 85–92% |
| Industrial Purity (HPLC) | ≥98.5% |
| Residual Solvents | <500 ppm (MeOH, H₂O) |
| Cyanide Residue | <10 ppm (ICP-MS verified) |
| COA Documentation | Full spectral (¹H/¹³C NMR, HRMS), HPLC, and elemental analysis |
Such stringent quality control ensures compatibility with GMP-aligned pharmaceutical development. The high industrial purity of this material is essential when used in downstream syntheses of bioactive molecules—such as the imidazole-4,5-dicarboxamide derivatives shown to inhibit dengue and yellow fever viruses at micromolar concentrations.
When sourcing high-purity Imidazole-4, buyers should prioritize suppliers with demonstrated expertise in nitrile-functionalized heterocycle manufacturing, robust analytical capabilities, and reliable bulk logistics. NINGBO INNO PHARMCHEM CO.,LTD. meets these criteria, offering competitive bulk price structures for metric-ton quantities and rapid global shipment with full regulatory support (REACH, TSCA, ISO 9001).
In summary, the synthesis of 1H-Imidazole-4,5-dicarbonitrile has evolved from academic curiosity to a streamlined industrial process. With its proven utility in antiviral drug discovery and materials science, access to high-quality, bulk DCI from a trusted global manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. is a strategic advantage for innovators in pharmaceutical and agrochemical R&D.